Johnson & Johnson (JNJ) Financial Statements (2023 and earlier)

Company Profile

Business Address ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
State of Incorp. NJ
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24,09533,49226,66620,43519,68718,296
Cash and cash equivalents14,12714,48713,98517,30518,10717,824
Short-term investments9,96819,00512,6813,1301,580472
Other undisclosed cash, cash equivalents, and short-term investments      
Receivables16,16015,28313,57614,48114,09813,490
Inventory, net of allowances, customer advances and progress billings12,48310,3879,3449,0208,5998,765
Inventory12,48310,3879,3449,0208,5998,765
Asset, held-for-sale, not part of disposal group    94950 
Other undisclosed current assets2,5561,8171,6511,2442,6992,537
Total current assets:55,29460,97951,23745,27446,03343,088
Noncurrent Assets
Property, plant and equipment19,80318,96218,76617,65817,03517,005
Intangible assets, net (including goodwill)93,55681,63889,79581,28278,06485,134
Goodwill45,23135,24636,39333,63930,45331,906
Intangible assets, net (excluding goodwill)48,32546,39253,40247,64347,61153,228
Deferred income tax assets9,12310,2238,534 
Other noncurrent assets9,60210,2166,5625,6954,1824,971
Other undisclosed noncurrent assets    7,8197,6407,105
Total noncurrent assets:132,084121,039123,657112,454106,921114,215
TOTAL ASSETS:187,378182,018174,894157,728152,954157,303
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities23,15929,36528,34923,87919,05419,421
Taxes payable1,1121,3922,2668181,854
Employee-related liabilities3,5863,4843,3543,0982,953
Accounts payable11,70311,0559,5058,5447,5377,310
Accrued liabilities11,45613,61213,9689,7157,6017,304
Debt12,8003,8002,6001,2002,8003,900
Other undisclosed current liabilities19,84312,06111,54410,8859,3767,216
Total current liabilities:55,80245,22642,49335,96431,23030,537
Noncurrent Liabilities
Long-term debt and lease obligation26,88829,98532,63526,49427,68430,675
Long-term debt, excluding current maturities26,88829,98532,63526,49427,68430,675
Liabilities, other than long-term debt27,88432,78436,48835,79934,28835,931
Accounts payable and accrued liabilities4,3065,7136,5597,4448,2428,472
Deferred tax liabilities, net5,9587,5068,368
Deferred income tax liabilities6,3747,4877,214 
Liability, pension and other postretirement and postemployment benefits 6,7678,89810,77110,6639,95110,074
Other liabilities10,43710,68611,94411,7348,5899,017
Other undisclosed noncurrent liabilities      
Total noncurrent liabilities:54,77262,76969,12362,29361,97266,606
Total liabilities:110,574107,995111,61698,25793,20297,143
Equity
Equity, attributable to parent76,80474,02363,27859,47159,75260,160
Common stock3,1203,1203,1203,1203,1203,120
Treasury stock, value(41,694)(39,099)(38,490)(38,417)(34,362)(31,554)
Accumulated other comprehensive loss(12,967)(13,058)(15,242)(15,891)(15,222)(13,199)
Retained earnings128,345123,060113,890110,659106,216101,793
Total equity:76,80474,02363,27859,47159,75260,160
TOTAL LIABILITIES AND EQUITY:187,378182,018174,894157,728152,954157,303

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues94,94393,77582,58482,05981,58176,450
Revenue, net76,450
Cost of revenue
(Cost of Goods and Services Sold)
(31,089)(29,855)(28,427)(27,556)(27,091)(25,354)
Gross profit:63,85463,92054,15754,50354,49051,096
Operating expenses(40,472)(40,525)(34,671)(34,689)(34,692)(32,691)
Operating income:23,38223,39519,48619,81419,79818,405
Nonoperating income (expense)(1,381)(436)(2,788)(2,168)(794)202
Investment income, nonoperating49053111357611385
Other nonoperating expense(1,871)(489)(2,899)(2,525)(1,405)(183)
Interest and debt expense(276)(183)(201)(318)(1,005)(934)
Income from continuing operations before equity method investments, income taxes:21,72522,77616,49717,32817,99917,673
Other undisclosed loss from continuing operations before income taxes      
Income from continuing operations before income taxes:21,72522,77616,49717,32817,99917,673
Income tax expense(3,784)(1,898)(1,783)(2,209)(2,702)(16,373)
Income from continuing operations:17,94120,87814,71415,11915,2971,300
Income before gain (loss) on sale of properties:20,87814,71415,11915,2971,300
Income from discontinued operations      
Net income available to common stockholders, basic:17,94120,87814,71415,11915,2971,300
Interest on convertible debt    111
Net income available to common stockholders, diluted:17,94120,87814,71415,12015,2981,301

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income:17,94120,87814,71415,11915,2971,300
Other comprehensive income (loss)912,184649(669)(1,791)1,702
Comprehensive income, net of tax, attributable to parent:18,03223,06215,36314,45013,5063,002

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: